Cover
Cover | Feb. 21, 2024 |
Cover [Abstract] | |
Document Type | 8-K/A |
Document Period End Date | Feb. 21, 2024 |
Entity Registrant Name | Arrowhead Pharmaceuticals, Inc. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-38042 |
Entity Tax Identification Number | 46-0408024 |
Entity Address, Address Line One | 177 E. Colorado Blvd |
Entity Address, Address Line Two | Suite 700 |
Entity Address, City or Town | Pasadena |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 91105 |
City Area Code | 626 |
Local Phone Number | 304-3400 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.001 per share |
Trading Symbol | ARWR |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Entity Central Index Key | 0000879407 |
Amendment Flag | false |